title: Time to request ABO-identity when transplanting for fulminant hepatic failure?
authors.affiliation: Department of Transplantation Surgery, Huddinge University Hospital, Stockholm, Sweden.
authors.forename: B G
authors.initials: BG
authors.lastname: Ericzon
authors.forename: K
authors.initials: K
authors.lastname: Bjoro
authors.forename: K
authors.initials: K
authors.lastname: Hoeckerstedt
authors.forename: B
authors.initials: B
authors.lastname: Hanssen
authors.forename: M
authors.initials: M
authors.lastname: Olausson
authors.forename: H
authors.initials: H
authors.lastname: Isoniemi
authors.forename: P
authors.initials: P
authors.lastname: Kirkegaard
authors.forename: G
authors.initials: G
authors.lastname: Soderdahl
authors.forename: A
authors.initials: A
authors.lastname: Foss
authors.forename: S
authors.initials: S
authors.lastname: Friman
mesh_terms: D000017:ABO Blood-Group System; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D017093:Liver Failure / Q000097:blood* / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods* / Q000401:mortality / Q000502:physiology; D012042:Registries; D012537:Scandinavian and Nordic Countries; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000017:ABO Blood-Group System